改变了女性大脑和微质细胞的新陈代谢和DAM特征,伴随着老化
Nicholas R W Cleland1, Garrett J Potter1, Courtney Buck1
1Division of Endocrinology, Metabolism and Diabetes, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Brain research
|January 20, 2024
概括
女性患阿尔茨海默氏病的风险可能与微质细胞中与年龄相关的代谢变化有关. 雌激素似乎抑制了与疾病相关的微质细胞因子,可能会影响风险,特别是绝经后.
科学领域:
- 神经科学是一个神经科学.
- 代谢过程中的代谢.
- 衰老研究研究 衰老研究
背景情况:
- 阿尔茨海默病 (AD) 对女性的影响不成比例,但潜在的机制尚不清楚.
- 微质代谢重编程与阿尔茨海默病理有关,但性别和年龄的影响未得到充分研究.
- 了解特定于性别和年龄的微质新陈代谢对于AD的发病过程至关重要.
研究的目的:
- 研究大脑和微质细胞中与年龄和性别相关的代谢变化.
- 探索雌激素在调节微质代谢和疾病相关微质 (DAM) 基因表达中的作用.
- 阐明将女性特异性代谢转变与阿尔茨海默病风险联系起来的潜在机制.
主要方法:
- 利用光终身成像显微镜 (FLIM) 进行全脑和微质细胞的代谢成像.
- 进行了转录基因分析,以评估微质中的基因表达.
- 使用17β-雌二醇 (E2) 补充的代谢试验和细胞系研究 (BV-2,MDMi).
主要成果:
- 女人的大脑表现出与年龄相关的转变,转向"类似男性"的糖分分析特征.
- 与男性相比,老年女性微质细胞表现出DAM基因和代谢途径基因的表达增加.
- 雌激素 (E2) 补充剂降低了DAM基因表达,脂质运输,并改变了微状细胞的新陈代谢;在老年雌性小鼠大脑中观察到升高的LPL活性.
结论:
- 改变的微质代谢是女性衰老的一个关键特征.
- 雌激素可能抑制与DAM相关的因素,可能导致绝经后妇女患AD风险增加.
- 研究结果强调了性别和年龄在微质代谢功能障碍和AD病变发生过程中的重要性.
关键词:
衰老的衰老 衰老的衰老阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.脂质 脂质 脂质 是一种脂蛋白脂酶是一种脂蛋白脂酶.代谢过程中的代谢.微质细胞中的微质细胞性差异性差异性差异性差异性差异性差异性差异性更多相关视频
14:57Preparation of Acute Hippocampal Slices from Rats and Transgenic Mice for the Study of Synaptic Alterations during Aging and Amyloid Pathology
Published on: March 23, 2011
94.1K
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
17.4K
相关概念视频
Aging
52
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
52
Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
